Published: May, 2018
Competition is heating up in the global thin film drug manufacturing market owing to astute players betting big on new products by investing heavily in cutting edge research and development. Expanding of production facilities to satisfy the ever-surging global demand is another strategy being deployed by them.
To thrive in the challenging environment, players are also seen banking upon mergers and acquisitions to tap into the synergies. This is resulting in consolidation in the global market for thin film drug manufacturing. Indivior Plc., MonoSol Rx, IntelGenx Corp., and ZIM Laboratories Limited are to name a few companies that have reached a place of prominence by banking upon the aforementioned strategies.
A recent research study by Transparency Market Research finds that the global market for thin film drug manufacturing will likely become worth US$15.984 bn by 2024 by rising at a solid 9.0% CAGR between 2016 and 2024. It valued the market at US$7.338 bn in 2015.
Among the different types of thin film drug manufacturing, the oral thin film is expected to gross maximum revenue in the next few years. This is because of its myriad benefits such as ability to administer drugs via the oral mucosa, ease of handling and transportation, ability to eliminate the hepatic first pass effect, and early action. The segment is expected rise at a phenomenal two digit CAGR of 18.3% during the forecast period. From a geographical standpoint, North America, powered by the U.S. where superior pharmaceutical research and growing demand of novel drug delivery is maximum, leads the market. So much so, the U.S. held about 85.3% market share in 2016.
Developed European Nations Majorly Boosting Sales Owing to Strong Awareness about Product
Developed European nations and the U.S. are at the forefront driving sales in the global market for thin film drugs on account of increased awareness about their solid efficiency in bringing about necessary therapeutic results and their ease of usage. Another reason why their demand in these nations is soaring is because of the absence of drawbacks of conventional forms of dosages in such novel products. Those include complicated administration and reduced bioavailability. On the contrary, they help administer appropriate dosages for the exact outcome. All such factors are catalyzing growth in the global market for thin film drug manufacturing. “Continued research and development, especially of innovative polymeric thin films, is also having a positive impact on the market,” adds the lead analyst of the report.
Players Eye Under-tapped Emerging Markets to Up Sales
A trend observed in the market for thin film drug manufacturing is key players looking towards the under-tapped emerging markets, particularly in Asia Pacific. India, Japan, and China hold out a lot of promise and overall, the region is expected to be buoyed by unveiling of new products, rising awareness, and supportive regulations.
This review is based on the findings of a TMR report, titled, “Thin Film Drug Manufacturing Market (Product - Oral Thin Film (Sublingual Film and Fully Dissolving Dental/Buccal Film), and Transdermal Thin Film; Disease Indication - Schizophrenia, Migraine, Opioid Dependence, and Nausea and Vomiting; Distribution Channel - Hospital Pharmacies, Drug Store, Retail Pharmacies, and E-Commerce) - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2016 – 2024.”
The report segments the Global Thin Film Drug Manufacturing Market into the following:
Global Thin Film Drug Manufacturing Market, by Product Type
- Oral Thin Film
- Sublingual Film
- Fully Dissolving Dental/Buccal Film
- Transdermal Thin Film
- Others (ocular thin film, etc.)
Global Thin Film Drug Manufacturing Market, by Disease Indication
- Opioid Dependence
- Nausea & Vomiting
Global Thin Film Drug Manufacturing Market, by Geography
- North America
- Rest of the Europe
- Asia Pacific
- Rest of Asia Pacific
- Latin America (LATAM)
- Rest of LATAM
- Middle East & Africa
- South Africa
- Saudi Arebia
- Rest of MEA
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Transparency Market Research
90 State Street,
Albany NY - 12207